It was observed during the routine, daily reporting of patient results that certain specimens were yielding unexpectedly abnormal values for plasma aspartate and alanine aminotransferase (AST, ALT) in the range 50 to over 100 U/L when assayed by the Technicon SMAC analyser. Examination of our quality control results did not reveal a problem. It was noted that some, but not all, of these specimens were a day old before the plasma was separated from the red cells, due to delay in transit. Blood pyruvate concentration is known to be substantially increased in this circumstance' and can be a principal source of error in aminotransferase assay.! It was therefore decided to investigate the effect of sample pyruvate concentration on these methods.
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AST and ALT measurements were performed, using the SMAC analyser, on aqueous pyruvate solutions and on a quality control serum spiked with added pyruvate. These experiments showed linear increases in apparent AST and AL T activities from 56 to 130 U/L and from 36 to 77 U/L respectively at added pyruvate concentrations from 0 to 1000 Jlmol/L (AST) and 0 to 800 Jlmol/L (ALT) respectively. For ALT at added pyruvate concentrations above 800 Jlmol/L, the SMAC software flagged the results as unacceptable because of non-linearity.'
To determine the potential magnitude of the increase in specimen pyruvate concentration in unseparated blood over 24 h, five fresh, heparinised blood specimens which had been submitted for SMAC analysis were selected at random. The mean and range of plasma pyruvate results were 138 Jlmol/L and 104-207 Jlmol/L. After 24 h at room temperature these same blood specimen tubes were briefly inverted, respun, and more plasma was removed for pyruvate analysis. The mean and range of pyruvate concentrations on these samples were now 2156 Jlmol/L and 2094-2332 Jlmol/L. This represents an average pyruvate increase of 84 Jlmol/L per h ( -60%/h) in the plasma that remained in contact with the red cells. It was about twice that reported for lactate" and Correspondence: D F Davidson. was similar to values published for whole blood pyruvate.' Therefore pyruvate levels sufficient to produce the effects mentioned above are likely to occur when specimens remain unseparated for several hours.
The ability of an aminotransferase assay to remove endogenous pyruvate during a preincubation period and thereby prevent interference is a function of both the time and the reagent lactate dehydrogenase (LDH) activity. Examination of the SMAC aminotransferase channels and assay of the reagent LDH activities at pH 7·0 and 37°C showed them to be in agreement with the manufacturer's method sheet. The SMAC, AST and ALT reagents were each mixed in their correct relative proportions and were found to give a final mix pH of8·2 at 37°C. To assess the effect of this finding, the LDH activity of the final reaction mix was measured at various pH values. This revealed a 90% decrease in LDH activity over the pH range 6·8-9·1, as shown in Fig. 1 . The SMAC AST method was reproduced on a spectrophotometer (SP8-100, Pye Unicam, Cambridge, UK) and the assay carried out at 37"C over a similar range of pH values. The sample was an aqueous pyruvate solution (500 Jlmol/L). The apparent AST activity increased from 5 U/L at a reaction pHof7'3t041 U/LatpH8·2 (Fig.l) .FurtherpH measurements of the other reagents revealed that the LDH/MDH/NADH and LDH/NADH reagent diluents, which had been produced inhouse on instruction of the manufacturer, had a pH at 20°C of 9·1. Commercially-obtained batches of the same reagents had a pH at 20°C of 8·7 which yielded a final mix pH of about 7·5 at 37°C and an apparent AST activity of only 7 U/L for the 500 Jlmol/L pyruvate solution. The susceptibility of the SMAC methods to interference from pyruvate was now much reduced at this lower pH.
Thus, one effect of the higher reaction mix pH was to decrease the LDH activity during the preincubation phase and hence reduce the ability of the reagent to remove endogenous pyruvate. Therefore, reduction of endogenous pyruvate continued during the period of monitoring of the In view of the sensitivity of this LDH preparation to relatively small changes in pH, close control is essential. Clearly, in the interests of accurate production of aminotransferase results by any type of analyser, a need exists for a more comprehensive study of the whole question of pyruvate interference. 
